New eye drops aim to soothe dry eyes with fewer doses
NCT ID NCT07422259
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether Reinnerva/Lubristil+G eye drops work better than Vismed for people with dry eyes. Forty adults with dry eye symptoms used one drop in each eye twice daily (Reinnerva/Lubristil+G) or four times daily (Vismed) for 60 days. Researchers measured tear production, tear film stability, and symptom scores to see which drop provided more relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Reinnerva/Lubristil+G sterile eye drops (artificial tears)
- What this could lead to
- If successful, this could offer a more convenient option for relieving dry eye symptoms with fewer daily applications.
- What could go wrong
- This is a small, completed post-market study with only 40 participants, so results may not apply to everyone. It compares two artificial tears, not a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONJUNCTIVITIS SICCA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UOC of Ophthalmology, AOU Policlinico "G. Martino"
Messina, 98125, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.